These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14761931)

  • 1. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective.
    Lane JT
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F442-50. PubMed ID: 14761931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microalbuminuria. From diabetes to cardiovascular risk].
    Monhart V
    Vnitr Lek; 2011 Mar; 57(3):293-8. PubMed ID: 21495411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephropathy: an overview for daily practice].
    Pittrow D; Wittchen HU; Bramlage P; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():39-44. PubMed ID: 14732949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.
    Abbott KC; Sanders LR; Bakris GL
    Arch Intern Med; 1994 Jan; 154(2):146-53. PubMed ID: 8285809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study.
    Pedro RA; Ramon SA; Marc BB; Juan FB; Isabel MM
    Ophthalmic Epidemiol; 2010 Aug; 17(4):251-65. PubMed ID: 20642348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus.
    Stehouwer CD; Donker AJ
    Neth J Med; 1993 Jun; 42(5-6):175-86. PubMed ID: 8377876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE; Damsgaard EM; Frøland A; Nielsen S; de Fine Olivarius N; Schmitz A
    Clin Nephrol; 1992; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic nephropathy].
    Agardh CD
    Nord Med; 1992; 107(8-9):215-6. PubMed ID: 1408727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.